Current and Emerging Approaches for Hepatic Fibrosis Treatment | Zendy

Jingguo Li | Zendy; Biguang Tuo | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Current and Emerging Approaches for Hepatic Fibrosis Treatment

Author(s) -

Jingguo Li,

Biguang Tuo

Publication year - 2021

Publication title -

gastroenterology research and practice

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.622

H-Index - 45

eISSN - 1687-630X

pISSN - 1687-6121

DOI - 10.1155/2021/6612892

Subject(s) - medicine , cirrhosis , hepatocellular carcinoma , liver fibrosis , liver transplantation , fibrosis , chronic liver disease , hepatic fibrosis , disease , intensive care medicine , bioinformatics , transplantation , biology

Liver fibrosis resulting from chronic liver injury is a key factor to develop liver cirrhosis and risk of hepatocellular carcinoma (HCC) which are major health burden worldwide. Therefore, it is necessary for antifibrotic therapies to prevent chronic liver disease progression and HCC development. There has been tremendous progress in understanding the mechanisms of liver fibrosis in the last decade, which has created new opportunities for the treatment of this condition. In this review, we aim to make an overview on information of different potential therapies (drug treatment, cell therapy, and liver transplantation) for the liver fibrosis and hope to provide the therapeutic options available for the treatment of liver fibrosis and discuss novel approaches.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research